Evidence map›Paper›PMID 38487405›Full record

ArticleMedical mycology case reports2024

Long-term survival following medical management of

Kiran G Kulirankal, Ann Mary, Merlin Moni, Gopal S Pillai, Dipu T Sathyapalan

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Medical mycology case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kiran G KulirankalDivision of Infectious Diseases, Department of Internal Medicine, Amrita Institute of Medical Sciences, Kochi, India.
Ann MaryDepartment of Internal Medicine, Amrita Institute of Medical Sciences, Kochi, India.
Merlin MoniDivision of Infectious Diseases, Department of Internal Medicine, Amrita Institute of Medical Sciences, Kochi, India.
Gopal S PillaiDepartment of Ophthalmology, Amrita Institute of Medical Sciences, Kochi, India.
Dipu T SathyapalanDivision of Infectious Diseases, Department of Internal Medicine, Amrita Institute of Medical Sciences, Kochi, India.
Amrita Institute of Medical Sciences and Research Centre · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A male in his 40's with no known comorbidities developed severe COVID-19 pneumonia and received a four-week course of methylprednisolone. The patient subsequently developed disseminated

Indexed as

Aspergillus fumigatusCOVID-19Covid pneumoniaDisseminated AspergillusFungal endocarditisInfectious diseases

Identifiers

PMID38487405
PMCPMC10937298
OpenAlexW4392360377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.